Skip to content

Managed Accounts with Banyantree

How we manage portfolios within an agreed mandate

Guide contents

Since 2015 we’ve done two jobs: we write cross-asset research, and we manage client portfolios. A research note says whether a stock is attractive. A portfolio has to decide whether it’s worth owning here, at this size, ahead of something else and inside your limits. This Guide is about that second job.

Short on time? Read Chapter 1 for who does what, Chapter 8 for the record and how it’s measured, and Chapter 9 for fees and conflicts.

Examples in this Guide are hypothetical unless they’re dated and attributed to our research. A dated research example records what we concluded at the time and says nothing about whether a managed portfolio bought or sold the stock.

Chapter 01

Delegating investment decisions

Here’s a typical adviser mandate. The adviser decides that 30% of a client’s portfolio belongs in Australian equities and hands us that 30%. We choose the companies and how much of each to own. If the client’s needs change, the adviser can cut it to 20%, even while we still like every stock we hold. The shares are our job; the allocation is theirs. We run mandates like this for adviser groups, family offices and investment committees.

Where our discretion stops

Whatever you hand us, the mandate draws a line. Inside it, we decide what to buy, hold, trim and sell, and when. Outside it, the call stays with you or whoever you’ve appointed.

The line matters most with a sleeve. No sleeve manager can reliably measure exposures in assets it can’t see. If another manager also owns the big banks, your bank exposure may be twice what either of us intends. If you want us to allow for that, we’ll agree which holdings you send us and how often, and manage to them. Otherwise the combined portfolio stays with you, or whoever oversees it.

A broader mandate also lets us move money between the asset classes you permit. The ranges you set still bind us, however wide the universe. Chapter 2 covers how they’re written.

SMA or IMA

The structure is a separate choice from how much you hand us. With a separately managed account (SMA), we run one model portfolio and the platform applies our changes to the accounts that follow it, through its own processes. With an individually managed account (IMA), we manage your portfolio to its own mandate, including your restrictions and the holdings you already own. Either way, the investments are held for you through a platform or custodian and show up in your account. Legal ownership, custody, transfer rights and how much detail you see depend on the account and provider. Your account documents set out how yours works.

Scroll sideways to see every column →

SMA and IMA compared
QuestionSMAIMA
Where we make decisionsFor one model, applied to every account in itFor your portfolio alone
What governs our choicesThe model’s mandate; the platform’s terms govern how changes are appliedYour mandate
Your restrictionsAs far as the model and platform support themAs agreed for your portfolio, within account and provider limits
Holdings you already ownTreated according to the model and platform rulesCan be assessed one by one
Best forOne consistent strategy across many accountsObjectives or constraints that need individual treatment

Two investors in the same SMA model still see different returns. They join at different times and prices, and their cash balances and restrictions differ.

As at November 2025, our clients’ accounts were on HUB24, Netwealth, MLC, Macquarie Wrap, Dash and Powerwrap/Praemium. Before you appoint us, we confirm that your strategy can run on the platform you use.

Who decides and who does what

Our investment team makes the decisions. It’s the same small team that writes our research and owns the firm, and you speak to them directly. Before Banyantree, members of the team worked at Morgan Stanley, Aberdeen Asset Management, RBC Capital Markets and IOOF (now Insignia Financial).

If you’re an adviser, the advice stays with you: whether a strategy suits your client, how much of their money goes into it, and when that should change. We manage the portfolio within its mandate.

Other parties carry our decisions out. On an SMA, the platform does the trading, custody and record-keeping for every account. On an IMA, who does that depends on how the account is held.

Before we start, we agree in writing who holds the assets, who instructs, executes and settles trades, and who records the holdings. We also agree who handles cash movements, corporate actions and exceptions, and the date our authority begins. Then we check that the account supports everything the mandate permits, including your exclusions.

Keep those lines in mind when you judge results: our decisions, your adviser’s allocation and your account’s costs each shape what you earn. Chapter 7 covers your account’s reporting and Chapter 8 the strategy records.

Chapter 02

Establishing the mandate

Say a family office plans to invest for ten years but has a large payment due in 18 months. The ten years lets it own investments that swing sharply in value. The payment means some of the money must be ready on time, even if markets are falling. Our strategies are managed to a five-to-seven-year horizon, so that payment needs its own plan.

The mandate has to make room for both. It sets out what the portfolio is meant to achieve, which decisions are ours and the limits that apply. If those requirements conflict, better stock picking won’t fix it.

Horizon and cash needs

So we look at when you’ll need money as closely as how long you’re investing. A ten-year objective for the whole portfolio doesn’t mean every holding runs on a ten-year basis. We also separate how much volatility you’re comfortable with from how much loss you can afford, especially if a payment falls due while markets are down.

In an IMA, we can hold cash or other liquid assets against a known payment. An SMA model is shared with other accounts and won’t hold extra cash for one investor, so the payment comes from elsewhere in their portfolio or from selling down their holding in the model. Either way, we agree up front where the money will come from.

How much room the mandate gives us

Our Australian equity strategies typically hold 20 to 35 companies. A multi-asset mandate can reach across shares, government and corporate debt, commodities, property, infrastructure, alternatives and cash. Allocation ranges then decide how far the mix moves.

If you allow growth and defensive assets but set a narrow range around each, we keep plenty of choice over what we hold and little room to shift money between the two. If that’s the control you want, we need to know before we take the portfolio on.

Restrictions can pull against the objective too. Exclude a large part of the universe and what’s left gets more concentrated. Keep a long-standing shareholding above a concentration limit, and the mandate has to say whether the holding is ours to manage, whether it counts towards the limit and what we’re allowed to do with it.

What the mandate needs to settle

We settle these before we start. For an IMA, we work through them with you and your adviser. For an SMA, the model’s mandate and the platform’s terms answer most of them already.

Scroll sideways to see every column →

What the mandate needs to settle
Matter to agreeQuestion it must settle
Objective and horizonWhat outcome is sought, and when may capital be needed?
Delegated authorityWhich decisions fall within our authority, and who approves decisions outside it?
Permitted investmentsWhich asset classes, securities, funds and instruments may be held?
Risk and allocation limitsWhich position limits, exposures or allocation ranges apply?
LiquidityWhat withdrawals or commitments must the portfolio be able to support?
Client-specific requirementsWhich exclusions, retained holdings or other conditions can the account accommodate?
Account and custodyCan the account, custodian and trading set-up support the agreed investments and restrictions?
Reporting and reviewWhat information will be provided, by whom and how often?

The table is a guide; your mandate and appointment documents set the binding terms.

When things change

Markets move a portfolio even when we don’t trade. A strong run in shares can lift a 70/30 portfolio towards 75/25 within months. Your circumstances change too: an earlier withdrawal, a new exclusion, a change of investment policy.

So the mandate separates targets from limits. A drift from a target is a judgement call, weighed against costs and our view of the holdings (Chapter 7). Crossing a binding limit triggers the response the mandate sets out, even when the market caused it. The mandate also says who we tell, who approves an exception and when new instructions take effect. We settle all this before a sharp move makes it urgent, and we report material breaches to you.

A narrow universe, tight concentration limits and a large near-term cash need can, together, leave too little room to pursue the objective. Then we’d rather fix the terms first, by changing the mandate or narrowing our job, before you ask us to use our discretion under them.

If your needs change later, we work out what that means for the portfolio and get your approval before acting outside our authority. Sometimes that means rewriting the mandate.

Chapter 03

From research to investment decisions

In December 2024, our research on Electronic Arts showed a business getting better and a share getting less attractive. Second-quarter revenue and earnings were ahead of expectations, net bookings reached US$2.08 billion and management raised its full-year guidance. The shares had also rallied. At US$167.01, they were trading close to our revised US$173.90 price target.

We downgraded our recommendation to Neutral while remaining positive about the company’s medium-term prospects. The stronger results supported the business case, but much of that improvement was already reflected in the share price.

That gap between a good business and a good price runs through all our research. A portfolio adds a second test. An investment can make sense on its own merits and still be unsuitable for the portfolio you’ve appointed us to manage.

What our research covers

The portfolios draw on the same research we publish. As at November 2025, it covered:

  • more than 1 million data points and over 80 macroeconomic indicators, tracked in our own models;
  • about 2,700 listed companies, screened across 23 developed and 24 emerging markets;
  • 120 to 150 Australian and 30 to 50 global companies under full coverage, each with a written note on our thesis and valuation at least twice a year;
  • more than 200 managed funds screened, with 60 to 90 under coverage at any time;
  • more than 200 ETFs screened every month;
  • data from Bloomberg, FactSet, Haver Analytics, BCA Research and Alpine.

A company goes through our own rating system, 20 indicators across three categories, before we do deep work on it. Coverage changes as ideas come and go. We also meet companies, visit sites and attend investment conferences here and overseas.

Testing the case

Every investment case starts with what has to happen for it to work: higher sales, better margins, less capital tied up or more cash coming in. We want to know which of those assumptions carries most of the value, and how much evidence sits behind it.

Our 9 April 2025 note on PEXA Group shows what that looks like when one company holds two very different businesses. Its established Australian exchange business had reported strong first-half results, while the UK operation remained behind plan and dependent on further lender approvals and regulatory milestones. We maintained our Buy recommendation at a share price of A$11.26, with a published price target of A$13.43. The two businesses had to be valued separately, because their prospects and risks were so different.

There’s rarely a final piece of information that settles a case like that. So we pin down the assumptions the conclusion leans on most, what an adverse outcome would do to the valuation and what evidence should make us look again. For PEXA, that meant progress through UK lender processes and regulatory approvals, alongside how the Australian business kept trading.

Before a view reaches a portfolio, the team pulls it apart. Someone questions the working-capital assumptions behind an earnings forecast. The valuation is rerun at lower growth and thinner margins. A macro argument has to survive the company-level evidence that cuts against it. The person responsible for the decision stays accountable for it.

Both examples come from our dated research, and neither tells you whether a managed portfolio held the stock. The ratings and price targets in these examples are from the original publication dates. They record our view at the time and shouldn’t be read as current recommendations or valuations.

Funds and ETFs

The questions change with the instrument. With a managed fund, we’re judging another team’s decisions: how its process turns into holdings, how it takes risk and whether its record fits that process.

Fees, liquidity and changes in the team can each weaken the case. For the 60 to 90 funds under coverage, we run an annual programme of manager meetings and due diligence, so you don’t have to sit through those meetings yourself.

An ETF brings a different set of choices. Its index rules, weights, costs and trading set the exposure you get. Knowing that an ETF provides “global equities” or “fixed income” tells you little if its holdings are concentrated in risks the portfolio already carries.

Macro research tells us where to look. The answer still comes from the company, fund or ETF itself.

Where research ends and the portfolio decision begins

A favourable note is the start of the portfolio question. Before it becomes a holding, four things have to line up: the stock is inside your mandate, the portfolio doesn’t already carry the same risk through other holdings, we can buy enough without moving the price, and nothing else offers a better use of the money.

Electronic Arts shows why. For a portfolio considering a first purchase, the share price against our revised valuation would matter most. For one already holding the shares, we’d also weigh the cost of selling, the risk the position adds and whether the money could work harder elsewhere. Continuing to hold an investment is itself a decision about how capital is allocated.

We keep the research and models behind each view, so we can later check what we knew, what we missed and what really changed the case.

Chapter 04

Portfolio construction and position sizing

A portfolio can own 15 well-researched investments and still be badly built. If 10 of them depend on credit staying easy to get, their different names and industry labels offer little comfort when financing tightens.

We judge every position as part of the whole: what it adds, what risk it brings, how much money it deserves and what we’d sell to make room. A modest return can earn its place if it brings liquidity or income the portfolio lacks.

How we invest

We start with the business and the price. What an asset trades for today can differ from what its future cash flows justify. Our research asks why the gap exists, what would close it and how much room the price leaves for us to be wrong.

We don’t stick to one style. Our positioning follows our highest-conviction ideas and the market we’re in. Because we tend to hold for a long time, we lean towards quality: businesses with the balance sheet and economics to compound. Our view of quality doesn’t always match the market’s. Quality isn’t worth any price, though. An excellent company can be a disappointing investment when too much success is already in the share price.

In direct equities, that produces a barbell. At one end sit quality businesses we expect to own for years; they’re the portfolio’s growth engine. At the other sit fewer, well-researched, high-conviction ideas the market follows less closely. We size those ideas for their downside and liquidity before we commit, and we change the mix as prices and evidence move.

We build portfolios that don’t hinge on any single call being right. In multi-asset mandates we look for opportunities across a broad range of asset classes, within the ranges your mandate sets. However good an idea looks, it gives us no licence to exceed your agreed limits.

How big a position gets

Conviction matters, but it can’t set the size of a holding on its own.

Say our central valuation puts a company well above its share price, but that value depends on refinancing debt, fixing a struggling division or winning a large contract. Each has its own odds and consequences. So a big discount to our valuation still comes with a wide range of outcomes.

So we ask what happens if the main assumption fails. Can the business fund itself? Would shareholders be diluted? What’s left in a bad outcome? A small position makes sense where the return looks attractive and the possible loss is large. The same idea at a much bigger weight wouldn’t.

Size also changes our ability to act. We build or cut a modest holding in a less liquid company over time. A large one often sells only at progressively lower prices, especially if the reason to sell turns up in a falling market. That alone can cap the allocation, however good the research case.

The rest of the portfolio matters as much. A stock deserves a bigger weight where little else shares its risk, and a smaller one where several holdings depend on the same conditions. Your mandate’s limits settle part of the question, and our judgement works inside them.

What would we sell to buy it?

Most new ideas arrive when the money is already invested. Buying means selling part of a holding, cutting a fund allocation or using cash we were keeping for liquidity or later opportunities.

A company we’ve followed for years is sound and performing as expected, but its share price has risen enough to cut the return from here. A new idea offers more upside, with less familiar operating risks or more exposure to financing conditions. Swapping one for the other changes the portfolio’s risks as well as its expected return.

Sometimes neither is clearly better. Then a partial switch can make more sense than selling the whole position, or the gain, after costs and the change in exposures, is too small to justify a trade at all.

Cash belongs in this comparison when the mandate permits it. It funds withdrawals and gives us room to act when prices move, and it costs something when the investments we pass over do well. We keep deliberate cash separate from cash that’s simply waiting during a transition, because they mean different things when you judge our return.

What we paid for a holding, and how much research we’ve put into it, explain how we got here. They can’t decide how much money it deserves now.

Benchmarks

In our direct-equity selection, benchmark weights don’t determine what we buy. We won’t buy a large index constituent because it’s large, or skip a smaller business because it barely registers, and our differences from the index follow from those decisions.

That cuts both ways. We’ve watched large index stocks keep rising after we’d decided their return was limited, and smaller companies we preferred lag for longer than we expected. We still measure the risk of being different from the market and check that it suits the mandate.

When we review results, we use a benchmark where it gives a meaningful comparison for the strategy and period. An Australian equity strategy and a diversified multi-asset portfolio shouldn’t be judged against the same equity index. Chapter 8 reports absolute returns and volatility.

Chapter 05

Managing portfolio risk

We plan on three to five market corrections a decade, and on nobody calling them in advance, us included. So we’re measured in the risk we take: we decide how much a holding could lose before we decide how much of it to own. We’ve managed client money through the COVID-19 sell-off, inflation and rapid rate rises, and senior members of the team managed money through the global financial crisis.

Those are the moments that test diversification. A bond allocation cushions a fall in shares in some downturns and falls right alongside them in others, especially when inflation is the trigger. The allocation tells us what the portfolio owns. We also need to know when its investments would lose value together, how quickly they’d sell and whether the portfolio would still meet your obligations.

When the price falls, what has changed?

A falling price improves the return on offer, shows that the original case was too optimistic, or does some of each. What has happened to the business tells us which.

If earnings and the balance sheet are sound and the shares fall because investors want higher returns from equities, the expected return has probably improved. A business losing a major customer, or one that’s lost access to refinancing, is a different matter: a lower price is little comfort if the value has fallen further.

The mixed cases are the hard ones. A temporary earnings setback can strain a company’s ability to service its debt, and the share price often moves before the damage shows in reported results. We reassess the valuation and our exposure while the answer is still unclear. Some businesses stay investable but deserve a smaller position once their downside has grown. Averaging down, or selling because the price moved, would skip the harder work of reassessing the business and its place in the portfolio.

The size of a loss on your statement tells only part of the story. Recovery depends on what caused the loss, whether the investment is still viable and whether you can leave the money invested long enough.

Risks that arrive together

Correlations measured in calm markets can break when it matters. We look for shared risks under different labels.

Take a portfolio with direct holdings in banks and property-related businesses. A specialist fund investing in leveraged companies from other industries looks like useful diversification. Tighter credit can hurt all three through different channels: loan losses, weaker property values and dearer financing. The industry labels differ; an important source of risk is shared.

That doesn’t rule the fund out. It changes how much of it we’d own and what else we’d trim. We look through fund and ETF holdings where they’re disclosed, to find overlapping securities and shared economic risks, and where disclosure leaves gaps, we allow for that in how much we hold.

Defensive assets share risks too. In a credit squeeze, a bond allocation heavy in corporate debt behaves differently from one built on government bonds.

Liquidity and withdrawals

An investment can be worth holding for the long term and still be the wrong source of cash next month.

A security that trades easily in normal markets gets expensive to sell when buyers step back. The last price may reflect a small trade, and selling a large position pushes it down. Some managed funds delay redemptions, and an ETF keeps trading while its spread widens.

Now picture a withdrawal falling due in a downturn. Even if the holdings are sound, the payment has to be funded, and selling after a fall leaves less invested for any recovery. For a family office paying distributions, the order of gains, losses and withdrawals can matter as much as the long-run average return.

Funding it from whatever is easiest to sell has another cost: what’s left ends up concentrated in things that are hard to sell. We look at what a withdrawal would leave behind, as well as how much cash it raises and what raising it costs. A long horizon helps only if the money actually stays invested, which is why expected withdrawals go into the mandate (Chapter 2).

When the mandate limits what we can do

Stress makes a mandate’s limits uncomfortable. A stock we like gets cheap but sits on your exclusion list. A scheduled withdrawal forces a sale when the remaining holdings look undervalued. We apply the limits anyway, in the way Chapter 2 sets out. An attractive investment case gives us no authority to override a restriction you’ve set.

Chapter 06

Implementation and portfolio transitions

A family office has owned shares in one Australian company for many years. The holding has grown to a quarter of its listed portfolio. The new mandate won’t allow that much concentration, but selling it all at once could bring a large tax bill and a worse price.

The family has good reasons to cut the concentration, and good reasons to question an immediate sale. A workable transition settles what to keep, what to change and how to get there through the new account.

What’s already in the account

We review every existing holding against the new mandate before deciding its fate. Some belong in the intended portfolio. Others fall outside the permitted universe, breach a limit or offer less than the alternatives. A holding you want kept for its own reasons is handled as Chapter 2 describes.

In an SMA, the model and platform rules decide what happens to inherited holdings. In an IMA, we agree the treatment of retained holdings and exclusions with you and check that the account can carry it out. Neither structure can promise to accommodate every holding or restriction.

So the portfolio we manage may start some way from the one we’d build with new money. We make sure you understand that difference before you appoint us.

Costs, tax and in-specie transfers

Selling and replacing a holding costs brokerage, bid-offer spreads, foreign-exchange charges and market impact.

Tax makes it harder. A position with a large unrealised gain is tempting to keep because selling would crystallise the tax. That doesn’t make it a good investment at today’s price. Keeping it also costs something if its expected return is poor, its risk has grown or it stops the portfolio meeting a limit.

So we weigh the benefit of moving against the cost of moving and the risk of staying put. A small improvement in expected return seldom justifies an immediate switch once costs and tax are counted. A deteriorating business or a binding limit justifies moving faster despite them.

Our role is investment management, and we don’t give tax advice. The tax effect of selling depends on your tax position, your ownership structure and which parcels are sold, so please check it with your tax adviser before relying on it.

We check whether eligible holdings can move in specie instead of being sold and bought back, which avoids needless trading. A transfer isn’t automatically tax-neutral, so your tax adviser should check that too, and a holding that moves across still has to earn its place.

How fast we move

If your portfolio is heavy in Australian equities and the new mandate allows a large allocation to global equities and defensive assets, moving fast cuts the old concentration. But selling big holdings together risks poor prices, and some redemptions and transfers take longer than buying on an exchange.

A staged transition spreads trades over time and allows more care with liquidity. Meanwhile you own something in between: retained positions keep their risks, and cash waiting to be invested cushions a fall or lags a rise.

Gaps open between trades too: sale proceeds settle after prices have moved, fund redemptions lag share purchases, and overseas markets add their own timing and currency.

We plan the order of trades as carefully as the target allocation, including the temporary exposures in between. An IMA can usually follow an agreed sequence, while an SMA transition is constrained by the model and the platform. Agreeing a portfolio on paper doesn’t make it executable through every platform, so we work through the timetable with you and the providers.

When the transition is complete

Until trades settle or a staged plan finishes, the holdings will differ from the intended portfolio, and an agreed legacy holding may stay for good or only until a planned sale. If you join an SMA that’s already running, you enter at today’s prices, and temporary cash and unsettled trades affect early returns.

The day our authority starts, the day the last asset arrives and the day the transition ends are often different. So we agree up front the date your account’s performance is measured from, and how transferred holdings, cash and transition trades are treated. If we show post-transition returns separately, we label them and keep them apart from the account’s earlier results and any strategy’s record.

Our transition review lists what was kept, sold and bought, any temporary positions still in place and what’s left to do. With the agreed reporting basis, it gives you a clean starting point for judging us from here.

Chapter 07

Ongoing management, reporting and oversight

A portfolio statement can show that we held a company for the entire year. It can’t show the decisions made along the way to keep it there.

Behind that one line there can be a year of decisions: an earnings beat, a lost customer, a rally that made the shares expensive, and three reviews that each ended with us keeping it. You should be able to see why we still own what we own, as well as why we made the trades on your statement.

What makes us reconsider a holding

We revisit an investment when new information changes the case for owning it, the return on offer at today’s price or the risk it adds to the portfolio. For a company we hold directly, the scheduled research notes in Chapter 3 also bring the thesis and valuation back up for review. For a managed fund, the trigger is usually a material change in holdings, process or people. An ETF’s role shifts as its index becomes more concentrated, even if we never trade it.

Take a company whose reported profit is rising while its operating cash flow falls. The cause matters. Extra inventory or a timing difference in receivables is one thing; customers paying late, or a need for more capital than we allowed for, is another. We find out which before we decide whether the holding changes.

Success raises its own question. A holding whose price has outrun our valuation offers less from here, and its bigger weight adds concentration. We can still like the company and want to own less of it. A better opportunity elsewhere can also shrink a position whose case hasn’t changed at all.

Deciding to keep a holding often takes as much work as deciding to sell it, and we explain both.

Rebalancing without trading for its own sake

Weights move even when we leave holdings alone. A strong performer becomes a bigger exposure, and contributions, withdrawals and market moves shift the balance between growth and defensive assets.

We review those movements against the mandate and our view of the investments. A position comes down when it’s too concentrated, its prospective return has fallen or the money is better used elsewhere. Otherwise, costs and a case that still stands justify leaving it alone.

We don’t use trading volume as a measure of investment effort. Binding limits stay binding, and anything outside our authority comes back to you for approval.

What you receive, and who you talk to

Every quarter you get an investment review that ties the portfolio’s holdings and results to the work behind them. It covers the main holdings and exposures, what changed and why, holdings we kept after new evidence tested them, and what we’re watching. Where the data support it, we show what drove the return. If something material happens between reviews, we get in touch then.

We also meet you one-on-one through the year to go through the portfolio, with attribution and risk analysis. For advisers, we write plain-language portfolio commentary you can pass on to clients, and we’re available to present at your client seminars. You talk to the investment team that made the decisions, with no relationship manager in between.

We tailor the detail to who’s reading. An adviser typically wants to know why a sizeable holding was cut while the company kept reporting well. A family office tends to focus on liquidity, concentration and how we fit with its other managers, and an investment committee on revisiting past decisions and the assumptions behind them.

The platform or custodian keeps the official record of holdings, transactions and valuations. A trade confirmation shows what we sold and at what price; our review explains why. At the start, we agree who supplies those records to us, who calculates your account’s return and how we investigate any gap between our reports and the official record.

Your account’s results differ from the strategy records in Chapter 8 because of entry prices, cash flows, restrictions and costs, and we report them on the basis agreed at the start (Chapter 6).

When a decision disappoints

A disappointing investment deserves more than a reference to difficult markets. We go back to the original case: which assumptions held, what changed and when the new information became available.

If a holding’s case depended on refinancing a large debt and the funding dried up, the review asks what we knew, or should have known, when we bought, how we weighed the risk and whether we resized the position as the window narrowed. A known risk we gave too little weight points to a flaw in the original decision. An event nobody could reasonably have foreseen doesn’t, though we still judge how we responded once it happened.

We apply the same discipline to our successes. A good result can make an uncertain decision look obvious in hindsight. The original assumptions and valuation tell us more about the quality of a decision than the profit does.

You can take any of these judgements up with the people who made them. You shouldn’t have to infer our reasoning from a holdings report.

Chapter 08

Strategies & Performance

Three strategies in our 2025 range are called Balanced. One combines managed funds and ETFs. Another uses ETFs alone. The third combines ETFs with directly held equities. All three target 50% growth assets and 50% defensive assets, yet their construction and inception dates differ.

The name tells you the target mix. It tells you little about what’s held, how the decisions are made or whether the results compare.

Our 2025 record covers 18 strategies, 12 of them with annualised return and volatility figures to 31 October 2025. Before you appoint us, we confirm which strategies are open to new appointments and talk through the record that matters for your mandate, limits included.

In this chapter: Strategy range · Equity results · Core MAS results · ETF and macro results · How to read these figures

Strategy range

The vehicle matters because it decides where the investment decisions sit and what costs and constraints come with them. MAS is our abbreviation for Multi-Asset Strategy.

Strategy range2025 record

Scroll sideways to see every column →

StrategyInceptionGrowth / defensiveTypical holdingsApproachFigures
Direct equity
Australian Core EquityJul 2015n/a20–35Australian shares; quality biasYes
Australian Dividend OpportunitiesMar 2017n/a20–35Australian shares; yield focusYes
Australian Small CompaniesApr 2017n/a20–35Australian shares; growth focusYes
Global Core EquityJan 2019n/a25–45Global shares; quality biasYes
Global Sustainable ESG Core EquityJan 2021n/a25–45Global shares; ESG focusNot published
Core multi-asset (MAS)
MAS ConservativeJul 201515% / 85%15–25Managed funds and ETFsYes
MAS Moderately ConservativeJul 201530% / 70%15–25Managed funds and ETFsYes
MAS BalancedJul 201550% / 50%15–25Managed funds and ETFsYes
MAS Moderate GrowthJul 201570% / 30%15–25Managed funds and ETFsYes
MAS GrowthJul 201595% / 5%15–25Managed funds and ETFsYes
ETFs only
ETF Moderately ConservativeMar 201830% / 70%8–20ETFs onlyNot published
ETF BalancedMar 201850% / 50%8–20ETFs onlyYes
ETF Moderate GrowthMar 201870% / 30%8–20ETFs onlyYes
ETFs and direct shares
Multi-Asset ModerateJan 202430% / 70%25–60ETFs and direct sharesNot published
Multi-Asset BalancedJan 202450% / 50%25–60ETFs and direct sharesNot published
Multi-Asset GrowthJan 202470% / 30%25–60ETFs and direct sharesNot published
Multi-Asset High GrowthJan 202490% / 10%25–60ETFs and direct sharesNot published
Unconstrained macro
Global Multi-Asset Macro StrategyMar 2017Not fixed60–80Unconstrained across asset classesYes

Growth and defensive percentages are targets; actual weights move over time. In the MAS and ETF strategies, holdings counts are funds and ETFs, which hold many securities of their own. The Multi-Asset strategies also hold shares directly.

Equity results

Annualised returns and volatilityTo 31 October 2025

Scroll sideways to see every column →

StrategyReported inceptionReturn p.a.Volatility p.a.
Australian Core Equity1 Jul 20151 Jul 201510.3%14.2%
Australian Dividend Opportunities20 Mar 201720 Mar 20179.1%12.6%
Australian Small Companies24 Apr 201724 Apr 20179.7%13.7%
Global Core Equity1 Jan 20191 Jan 201916.6%15.4%

Returns shown are before Banyantree management fees, platform fees and transaction costs. Source: Bloomberg PORT. Past performance is not a reliable indicator of future performance.

These four strategies do different jobs. Dividend Opportunities looks hard at whether a company’s dividends are sustainable, Small Companies carries more financing and liquidity risk, and Global Core Equity adds other markets and currencies. Their records also start in different years, so we don’t rank them against each other. A fair comparison needs the same dates and a suitable market reference.

Core MAS results

Five core MAS strategies over a common period1 July 2015 to 31 October 2025

Scroll sideways to see every column →

StrategyTarget growth / defensiveReturn p.a.Volatility p.a.
MAS Conservative15% / 85%15% / 85%4.2%2.7%
MAS Moderately Conservative30% / 70%30% / 70%5.1%4.0%
MAS Balanced50% / 50%50% / 50%5.9%5.6%
MAS Moderate Growth70% / 30%70% / 30%6.7%7.2%
MAS Growth95% / 5%95% / 5%8.0%9.4%

Returns shown are before Banyantree management fees, platform fees and transaction costs. Source: Bloomberg PORT. Past performance is not a reliable indicator of future performance.

These five records are the easiest to compare, because they share the same start and end dates. Over that period, each step up in target growth allocation came with a higher reported annualised return and higher volatility.

That’s the pattern you’d expect, but it describes one period. The growth target is only part of the risk picture; what each portfolio holds, and the decisions made inside it, matter too. If you draw on the portfolio regularly, the path of returns and the size of the falls matter more than the highest long-run average (Chapter 5).

ETF and macro results

Annualised returns and volatilityTo 31 October 2025

Scroll sideways to see every column →

StrategyReported inceptionReturn p.a.Volatility p.a.
ETF Balanced12 Mar 201812 Mar 20186.6%7.0%
ETF Moderate Growth12 Mar 201812 Mar 20188.2%9.5%
Global Multi-Asset Macro StrategyMar 2017Mar 20178.3%7.0%

Returns shown are before Banyantree management fees, platform fees and transaction costs. Source: Bloomberg PORT. Past performance is not a reliable indicator of future performance.

In the ETF strategies, our decisions are which exposures to hold and how much of each. The index behind each ETF decides much of what it owns.

ETF Balanced and MAS Balanced both target 50% growth assets, but the ETF strategy started almost three years later and gets its exposure a different way. Their figures can’t tell you which approach did better over a comparable period.

The macro strategy has no fixed growth/defensive split and works across asset classes without set allocations. Figures similar to the MAS portfolios wouldn’t mean similar risks or a similar purpose.

How to read these figures

All figures are to 31 October 2025.

We present historical strategy returns as annualised total returns from each reported inception date to 31 October 2025. Volatility is shown as annualised standard deviation. The reported figures are sourced from Bloomberg PORT. The reported returns are before Banyantree management fees, platform fees and transaction costs. Our management fee is 0.25% a year (see Chapter 9). Platform and transaction costs vary by account.

An annualised return is the equivalent yearly rate over the whole period. A strategy reporting 8% a year didn’t necessarily earn 8% in any single year, and the timing of your contributions and withdrawals changes what you would have earned.

Volatility measures how widely returns varied around their average. It leaves out how far a portfolio fell from its peak, how long recovery took and whether holdings could be sold in a bad market. When we review a strategy, we look at those drawdowns too, knowing the worst fall on record need not be the worst to come.

These are strategy records. Your account’s return depends on when you joined, your cash flows, restrictions and charges, and the transition described in Chapter 6.

A benchmark-relative figure needs its benchmark, currency, period and method spelled out. A broad equity index gives useful context for a direct-equity strategy, while a portfolio with large defensive holdings needs a different reference. The tables above show absolute returns and volatility.

We haven’t published return or volatility figures to 31 October 2025 for Global Sustainable ESG Core Equity, ETF Moderately Conservative or the four Multi-Asset strategies that began in January 2024. We include them so you can see the full 2025 range. We haven’t filled the gaps with estimates.

Source: Banyantree Investment Group; Bloomberg PORT. Figures reported to 31 October 2025. Current strategy availability is confirmed before appointment. For wholesale and professional investors. Past performance is not a reliable indicator of future performance.

Chapter 09

Fees, incentives, conflicts and appointment

Two portfolios can pay us the same fee and have very different total costs. One holds Australian shares directly. Another holds active managed funds, ETFs and overseas securities through a platform. Our fee, the investments’ own costs and the account charges have to be looked at together.

How we’re paid matters too. The investment team owns Banyantree, writes the research and manages the portfolios. That gives us a direct stake in doing the work well, and it creates interests you should understand before you appoint us.

Our fee and what it covers

Our Managed Accounts fee is 0.25% per annum of funds under management. We don’t charge a Banyantree performance fee. Your appointment documents set out how the management fee is calculated and paid, including valuation dates, billing, GST and any terms specific to the mandate. If the fee base remains at A$1 million for a full year, the 0.25% annual management fee would be A$2,500, before GST and other costs.

The fee covers building and running the portfolio within your mandate, the research behind it, the reporting and meetings described in Chapter 7, and direct access to the team making the decisions. The exact service depends on whether you use one of our strategies or an individual mandate.

The portfolio also pays the costs of the account and of what it holds: platform or custody charges, brokerage, bid-offer spreads, foreign exchange and market impact. Managed funds and ETFs carry their own expenses, mostly inside the unit price, so they won’t appear as separate lines on your statement. Some underlying funds charge performance fees even though we don’t.

We treat those costs as part of the investment decision. A fund with a convincing process can still charge too much to leave investors a good return, and a cheaper ETF can be the poorer holding if its exposure or liquidity is wrong. A more expensive option has to earn its extra cost.

Before you appoint us, we set out our fee and the expected external costs for your account, so you can see the whole cost. Any fee your adviser charges is separate, agreed between you and them.

The incentive our fee creates

With no performance fee, we get nothing extra for beating a hurdle or a benchmark, and the rate stays the same in good years and bad.

A fee on assets still creates an incentive. When the assets we manage grow, through returns or new money, our revenue grows; withdrawals and falling markets shrink it. So we have a commercial interest in winning and keeping assets.

That interest stays out of the investment decision. If your circumstances call for less risk, a withdrawal or a narrower mandate, we deal with that on its merits. We won’t keep a holding to protect fee revenue, or push your risk up because a higher return would grow the assets we manage.

Ownership and independence

Banyantree is 100% owned by its investment team. No parent company or outside shareholder sets a house view for us to follow. The people writing the research and managing the portfolios also carry the firm’s reputation and economics.

We draw heavily on outside data and research, and the conclusions stay ours. We can disagree with an issuer, a fund manager or the consensus without having to support an owner’s product or position.

Ownership also concentrates responsibility in a small team. Shared research, models and decision records let others in the firm revisit earlier assumptions and follow the reasoning behind a decision. The work still depends on the judgement of the people managing your portfolio, and key-person risk is something you should weigh when you assess the appointment.

Fund managers, issuers and platforms don’t pay us for research coverage, inclusion or placement. We receive no rebates, shelf-space payments or referral fees. We don’t operate a broking, investment-banking or capital-raising business.

Those exclusions remove some reasons to favour one provider or security. Other conflicts remain, and the next section covers how we handle them.

Research, trading and fair treatment

The same team writes our research and manages the portfolios. A research subscriber reads our view and decides what to do with it. For a managed portfolio, we make that decision within your mandate.

That raises a question of timing. A portfolio decision can be made while the research behind it is still being written, before the note goes out. Publication can also move a less liquid stock while portfolios are trading it. So we control who sees research before release, how publication and trading are sequenced, and how the team trades for itself.

Front-running, misuse of client order information and allocation that favours one client for an improper reason aren’t permitted.

Fairness between clients needs the same care. When several portfolios want the same thinly traded stock at once, there may not be enough liquidity to fill every order on the same terms. We allocate under set procedures and record material decisions. Where a platform or broker allocates trades, its rules apply too, and we agree who does what before we start.

Portfolios will still end up different for legitimate reasons. One adviser’s client withdraws money while another account has cash to invest, or an IMA excludes a stock the SMA model holds. Those differences come from the mandates and the accounts themselves.

Other conflicts can come from personal holdings, outside interests, gifts, counterparties and confidential information. If a conflict can’t be managed properly, the activity doesn’t go ahead. Our Conflicts of Interest Policy and Research Independence Policy set out how we manage them.

Using our research as well

You can appoint us without taking out a research subscription. Research subscribers pay for the research programme and make their own decisions. Managed Accounts clients hand us specified decisions within a mandate. An adviser can use both, applying our research across the practice while we manage a sleeve or a portfolio. What a managed appointment includes in publications and commentary is set out in its terms.

Starting, changing or ending an appointment

We start with the portfolio you have, what you want it to achieve and which decisions you’d hand over.

Then we work out which strategies and accounts are available to you, who will hold and trade the assets and which restrictions the account supports.

We also settle how responsibility splits between us, you, your adviser and the providers. Minimum account sizes and platform requirements are part of that conversation.

Before you appoint us, we go through the strategy’s current record and risks. We agree the scope and limits of our authority, the reporting, the fee and expected external charges, and how an existing portfolio would move across.

Sometimes a requirement has to change first. If a restriction stops the strategy doing what you expect, or a holding creates a concentration the mandate won’t allow, we’d rather narrow the job, change the set-up or decline than accept a portfolio we can’t manage on the agreed terms.

Your appointment documents also set out how to change or end the appointment.

Your appointment is governed by its agreed documents. Read this Guide with our Disclaimer.